Follow-On Biologics Bill Could Be Shaped By Waxman/Dingell Fight For House Commerce Cmte.
Chairmanship would give Waxman more leverage to place regulatory flexibility into the biosimilars approval pathway.
Chairmanship would give Waxman more leverage to place regulatory flexibility into the biosimilars approval pathway.